Augusto Villanueva

@augustoNYC

Translational research in liver cancer. Working at . Executive Secretary of . Views are my own. Like/retweet ≠ endorsement.

New York
Vrijeme pridruživanja: rujan 2011.

Tweetovi

Blokirali ste korisnika/cu @augustoNYC

Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @augustoNYC

  1. proslijedio/la je Tweet
    prije 9 sati

    Chaired by Dr. Amit Singal and Dr. Tim Meyer and with an expected 150 participants this year’s single topic workshop has plentiful opportunities to learn and network!

    Poništi
  2. proslijedio/la je Tweet
    prije 13 sati

    Female talent: scientists speak out: What obstacles have you encountered as a female scientist? What advice would you give female researchers who are starting out? Isabel Graupera () responds

    Poništi
  3. proslijedio/la je Tweet
    31. sij

    wonderful deep dive on intra-tumour heterogeneity in liver cancer- fascinating interplay of spatio-temporal immune/cancer cell interactions

    Prikaži ovu nit
    Poništi
  4. proslijedio/la je Tweet
    30. sij

    Can we apply this to ? a disease in great need for prevention/interception, ideas you guys have brilliantly advocated for . Great opportunity in this space given the ability to access liver with drugs/small RNAs.

    Poništi
  5. proslijedio/la je Tweet
    27. sij

    Attend ILCA's new educational activity! The Single-Topic Workshop will delve into the prevention, risk stratification and early detection of HCC-related diseases

    Poništi
  6. proslijedio/la je Tweet
    27. sij

    CDC confirms 3 new cases of novel () infection in the U.S., 1 in AZ & 2 in CA, bringing total to 5. All US cases travelled from Wuhan, China. More cases may be identified. However, risk to US general public is still considered low.

    Poništi
  7. proslijedio/la je Tweet
    24. sij

    Open Access!! The 2019 WHO classification of tumours of the digestive system

    Poništi
  8. proslijedio/la je Tweet
    24. sij

    Terrific thought exercise by about the increasingly small volumetric percentage of tumor sampled by biopsies as mass size increases, potentially missing a vast swath of heterogeneity

    Poništi
  9. proslijedio/la je Tweet
    24. sij

    . explains that ‘one of these things is not like the other’ wherein HCC distinguished itself transcriptomally from nearly all other solid tumors

    Poništi
  10. proslijedio/la je Tweet
    24. sij

    Atezo/bev vs Sorafenib in advanced HCC, time to deterioration in quality of life favors atezo/bev.

    Prikaži ovu nit
    Poništi
  11. proslijedio/la je Tweet
    24. sij
    Poništi
  12. proslijedio/la je Tweet
    23. sij

    ILCA 2020 website is now live! Submit your abstract and discover the preliminary scientific programme and the topics to be presented during the conference in Madrid this September!

    Poništi
  13. 21. sij

    Bruce Lee with Lightsaber Nunchuks! via

    Poništi
  14. proslijedio/la je Tweet
    18. sij

    Por cierto, en TCM empieza “12 hombres sin piedad”. De nada.

    Poništi
  15. proslijedio/la je Tweet
    15. sij

    Cada vez falta menos para el Os esperamos a todos en Santiago de Compostela

    Poništi
  16. proslijedio/la je Tweet
    16. sij

    A full issue of ⁦⁩ dedicated to primary liver cancer !

    Poništi
  17. proslijedio/la je Tweet
    15. sij

    Heterogeneity of liver cancer cells helps explain tumor progression in patients via

    Poništi
  18. 15. sij

    Quick poll on clinical impact of molecular heterogeneity in HCC

    Poništi
  19. proslijedio/la je Tweet
    15. sij

    Very interesting work on intra tumoral heterogeneity (ITH) in liver cancer! Multiregional omics data from 71 samples (N = 14 patients) shows ITH in 30–40% of treatment-naive They see different clonal expansion of adaptive immune system in distant regions of the same tumor

    Poništi
  20. 15. sij

    Our paper mapping intra-tumoral HCC heterogeneity, transcriptomic dynamics and clinical impact using out in . Great job and , awesome collab with and .

    Poništi

Čini se da učitavanje traje već neko vrijeme.

Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.

    Možda bi vam se svidjelo i ovo:

    ·